Background: Adults who suffer from traumatic brain injury often die from it,
become permanently disabled, and incur significant costs to the healthcare
system. We aimed to compare the effects of hypertonic sodium and mannitol on
intracranial pressure change from baseline, and significant adverse events in
patients who have had acute traumatic brain injury. Method: The databases of
Cochrane, EMBASE, CENTRAL, and PubMed were searched for published
articles between 2008 and 2023. We looked for human researches. Bibliographies
and recommendations for clinical practice were examined. Studies about the
comparison between mannitol and HTS in randomized trials for people with
acute traumatic brain injury were collected. Results: Six RCTs were included in
the systematic review after duplicates and irrelevant studies were eliminated
from the chosen publications. We looked at 336 patients in total from the six
RCTs. ICP was lowered by 45% of the mean baseline values in patients receiving
mannitol infusion for 60 minutes, compared to 35% of the baseline values in the
HTS group. Mannitol was just as successful as HTS in lowering ICP, but neither
drug was able to enhance brain metabolism. Conclusion: MTL was equally
successful in lowering ICP as HTS was in the cases of cerebral ischemia, HTS
demonstrated better result on cerebral perfusion, which could be helpful.
Keywords: Traumatic brain injury, elevated intracranial pressure, management,
systematic review
